Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | APEX1 | P27695 | 3/20 | 0.38 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 5/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | SMOX | Q9NWM0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28916544 | 0.98 | APEX1 (0.40) | MEN1KMT2AAPEX1ACHENFKB1 | |
| SCHEMBL5154412 | 0.93 | MEN1 (0.42) | MEN1KMT2AAPEX1ACHENFKB1 | |
| SCHEMBL12047846 | 0.91 | MEN1 (0.46) | MEN1KMT2AAPEX1ACHENFKB1 | |
| Hydrochloric Acid SCHEMBL28686190 | 0.90 | MEN1 (0.44) | MEN1KMT2AAPEX1ACHENFKB1 | |
| Hydrochloric Acid SCHEMBL2021971 | 0.90 | APEX1 (0.48) | MEN1KMT2AAPEX1ACHENFKB1 | |
| Water SCHEMBL4405264 | 0.84 | LMNA (0.31) | LMNA | |
| Hydrochloric Acid SCHEMBL28596004 | 0.84 | APEX1 (0.32) | APEX1NPSR1 | |
| SCHEMBL176501 | 0.83 | LSS (0.37) | KDM1APAOXCNR1CNR2SMOX | |
| SCHEMBL19630714 | 0.81 | DNM1 (0.40) | KMT2AKDM1APAOXCNR1CNR2 | |
| SCHEMBL4782686 | 0.79 | DNM1 (0.43) | KMT2AKDM1ACNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1014999-B1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GENZYME CORP (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1014999-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-07-05 | — | — | EP | claimed |
| WO-1999015186-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | claimed |
| EP-3181227-A1 | POLYMERIC FUNCTIONAL MEMBRANE FOR REMOVING NITRATE IONS, PRODUCTION METHOD THEREFOR, SEPARATION MEMBRANE MODULE, AND ION EXCHANGE DEVICE | Fujifilm Corporation (JP) | 2017-06-21 | — | — | EP | disclosed |
| EP-2423180-B1 | QUATERNARY AMMONIUM COMPOSITION | CLARIANT INT LTD (CH) | 2016-07-06 | — | — | EP | disclosed |
| EP-2423180-A1 | Quaternary ammonium composition | Clariant Finance (BV) Limited (VG) | 2012-02-29 | — | — | EP | disclosed |
| EP-2159276-A1 | Solid or gel surfactant composition | Clariant (Brazil) S.A. (BR) | 2010-03-03 | — | — | EP | disclosed |
| US-7348303-B2 | Quaternary ammonium composition | CLARIANT INTERNATIONAL, LTD. (CH) | 2008-03-25 | — | — | US | disclosed |
| US-20060135389-A1 | Quaternary Ammonium Composition | CLARIANT INTERNATIONAL LTD. (CH) | 2006-06-22 | — | — | US | disclosed |
| US-6897187-B2 | Light duty liquid cleaners comprising a monoalkoxylated quaternary ammonium surfactant | CLARIANT INTERNATIONAL LTD. (CH) | 2005-05-24 | — | — | US | disclosed |
| US-20050020473-A1 | Liquid all-purposes cleaners | GALLOTTI MANLIO (BR) | 2005-01-27 | — | — | US | disclosed |
| US-20020114774-A1 | Ionic polymers as toxin-binding agents | GELTEX PHARMACEUTICALS, INC. | 2002-08-22 | — | — | US | disclosed |
| WO-2001094511-A1 | LIQUID ALL-PURPOSE CLEANERS | CLARIANT INTERNATIONAL LTD (CH) | 2001-12-13 | — | — | WO | disclosed |
| EP-1162254-A1 | Liquid all-purpose cleaners | CLARIANT INTERNATIONAL LTD. (CH) | 2001-12-12 | — | — | EP | disclosed |
| EP-1158040-A1 | Light duty liquid cleaners | CLARIANT INTERNATIONAL LTD. (CH) | 2001-11-28 | — | — | EP | disclosed |
| WO-2001088073-A1 | LIGHT DUTY LIQUID CLEANERS | CLARIANT INTERNATIONAL LTD (CH) | 2001-11-22 | — | — | WO | disclosed |
| US-6290947-B1 | IN ONE EMBODIMENT, THE POLYMER IS A COPOLYMER COMPRISING A MONOMER HAVING A PENDANT AMMONIUM GROUP AND A HYDROPHOBIC MONOMER. | GELTEX PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | disclosed |
| EP-1014999-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-07-05 | — | — | EP | disclosed |
| US-6007803-A | ADMINISTERING TO MAMMAL A CATIONIC POLYMER TO INHIBIT PATHOGENIC TOXINS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1999015186-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020114774-A1 | Ionic polymers as toxin-binding agents | PIGS, ANTXR2, MSN | MEN1 1450/4885KMT2A 3812/4885APEX1 1662/4885 |
| US-20060135389-A1 | Quaternary Ammonium Composition | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, SLC10A6 | MEN1 2768/4885KMT2A 1092/4885APEX1 3674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.